Cocrystal Pharma (COCP) Non-Current Deffered Revenue (2015 - 2018)
Cocrystal Pharma (COCP) reported Non-Current Deffered Revenue of $10000.0 for Q3 2018, down 72.97% on a YoY basis from $37000.0 in Q3 2017, and down 41.18% sequentially from $17000.0 in Q2 2018.
Cocrystal Pharma (COCP) Non-Current Deffered Revenue (2015 - 2018) Analysis & Trends
Cocrystal Pharma (COCP) has 4 years of Non-Current Deffered Revenue data on file, last reported at $10000.0 in Q3 2018.
- For the quarter ending Q3 2018, Non-Current Deffered Revenue fell 72.97% year-over-year to $10000.0; the trailing twelve-month figure through Sep 2018 stood at $10000.0 (down 72.97% YoY), and the FY2017 full-year result was $31000.0, down 50.79% from the prior year.
- Non-Current Deffered Revenue fell to $10000.0 in Q3 2018, from $17000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $63000.0 in Q4 2016 to a low of $10000.0 in Q3 2018.
- A 4-year average of $38700.0 and a median of $39500.0 in 2017 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue increased 3.28% in 2016 and plunged 72.97% in 2018, its largest moves.
- Tracing COCP's Non-Current Deffered Revenue over 4 years: stood at $61000.0 in 2015, then increased by 3.28% to $63000.0 in 2016, then plunged by 50.79% to $31000.0 in 2017, then plunged by 67.74% to $10000.0 in 2018.
- Business Quant data shows COCP's Non-Current Deffered Revenue at $10000.0 in Q3 2018, $17000.0 in Q2 2018, and $25000.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 10,000.00 |
| Jun 30, 2018 | 17,000.00 |
| Mar 31, 2018 | 25,000.00 |
| Dec 31, 2017 | 31,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Jun 30, 2017 | 42,000.00 |
| Mar 31, 2017 | 47,000.00 |
| Dec 31, 2016 | 63,000.00 |
| Sep 30, 2016 | 54,000.00 |
| Dec 31, 2015 | 61,000.00 |